CLINICAL STUDIES

Select

Semaglutide effects on cardiovascular outcomes in people with overweight or obesity

Study Phase:

Phase 3b

Criteria:

  • Male or Female 45 years or older
  • Body mass index (BMI) ≥ 27 kg/m2
  • History of Cardiovascular Disease
Register